Hepatocellular carcinoma (HCC) is an extremely prevalent malignancy that is the fourth world wide. It is an important contributor to the mortality of those with chronic liver diseases in both developing and developed countries. Early detection of cancer offers the best chance for cure; this is why screening for HCC is recommended on regular basis. Screening may involve blood tests to detect the level of tumor markers in serum and radiological tests including CT, MRI and ultrasound imaging. In the current work, the detection possibility of the structural changes in serum proteins ...